mAbxience Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
1,300
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
2
mAbxience General Information
Description
Operator of a biopharmaceutical company dedicated to contributing to the sustainability of healthcare systems worldwide. The company specializes in the development, manufacturing, and commercialization of monoclonal antibodies at facilities in Spain and Argentina, thereby helping healthcare providers to treat and prevent diseases across different therapeutic areas.
Contact Information
Website
www.mabxience.com(Operating Subsidiary)
Corporate Office
- Manuel Pombo Angulo 28
- 2nd floor
- 28050 Madrid
- Spain
Corporate Office
- Manuel Pombo Angulo 28
- 2nd floor
- 28050 Madrid
- Spain
mAbxience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
mAbxience Comparisons
Industry
Financing
Details
mAbxience Competitors (1)
One of mAbxience’s competitors is AGC Pharma Chemicals, a Corporate Backed or Acquired company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AGC Pharma Chemicals | Corporate Backed or Acquired | Barcelona, Spain |
mAbxience Signals
mAbxience Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
mAbxience FAQs
-
When was mAbxience founded?
mAbxience was founded in 2010.
-
Where is mAbxience headquartered?
mAbxience is headquartered in Madrid, Spain.
-
What is the size of mAbxience?
mAbxience has 1,300 total employees.
-
What industry is mAbxience in?
mAbxience’s primary industry is Biotechnology.
-
Is mAbxience a private or public company?
mAbxience is a Private company.
-
What is the current valuation of mAbxience?
The current valuation of mAbxience is .
-
What is mAbxience’s current revenue?
The current revenue for mAbxience is .
-
Who are mAbxience’s investors?
Insud Pharma has invested in mAbxience.
-
Who are mAbxience’s competitors?
AGC Pharma Chemicals is a competitor of mAbxience.
-
When was mAbxience acquired?
mAbxience was acquired on 01-Oct-2026.
-
Who acquired mAbxience?
mAbxience was acquired by Fresenius.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process